<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">In terms of therapeutics there is no known effective pharmaceutical agent. There are over 200 registered clinical trialsÂ registered in China alone. Putative agents include antivirals; Griffithsin, a spike protein inhibitor, nucleoside analogues eg. remdesivir, ribavirin and protease inhibitors such as lopinavir/ritonavir. Immunomodulatory and other host targeted agents include interferon, chloroquine and immunoglobulins. Corticosteroids will potentially have benefit for immune mediated lung damage late in the course of disease [
 <xref ref-type="bibr" rid="CR6">6</xref>]. Much of the theory stems from what we have learnt from limited trials in other corona viruses [
 <xref ref-type="bibr" rid="CR7">7</xref>].
</p>
